Fidelity Investments
ACIU icon

Fidelity Investments’s AC Immune ACIU Stock Holding History

Fidelity Investments’s Portfolio ACIU Stock Details ACIU Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q3 		– Sell
-27,202
Closed -$109K – 5476
2024
Q2 		$109K Hold
27,202
– – ﹤0.01% 3270
2024
Q1 		$80.5K Hold
27,202
– – ﹤0.01% 3374
2023
Q4 		$136K Buy
+27,202
New +$87.4K ﹤0.01% 3097
2022
Q3 		– Sell
-42
Closed – – 4796
2022
Q2 		$0 Sell
42
-9
-18% -$31 ﹤0.01% 4863
2022
Q1 		$0 Sell
51
-1
-2% -$4 ﹤0.01% 4903
2021
Q4 		$0 Sell
52
-2
-4% -$12 ﹤0.01% 4261
2021
Q3 		$0 Sell
54
-1
-2% -$7 ﹤0.01% 4262
2021
Q2 		$0 Sell
55
-14,032
-100% -$97K ﹤0.01% 4170
2021
Q1 		$107K Sell
14,087
-4
-0% -$29 ﹤0.01% 2911
2020
Q4 		$73K Sell
14,091
-3,502
-20% -$17.9K ﹤0.01% 2938
2020
Q3 		$86K Sell
17,593
-49,701
-74% -$357K ﹤0.01% 2812
2020
Q2 		$452K Sell
67,294
-23
-0% -$167 ﹤0.01% 2526
2020
Q1 		$466K Sell
67,317
-141
-0.2% -$1.1K ﹤0.01% 2445
2019
Q4 		$575K Sell
67,458
-47,617
-41% -$317K ﹤0.01% 2480
2019
Q3 		$569K Sell
115,075
-1,286,481
-92% -$6.89M ﹤0.01% 2502
2019
Q2 		$7.78M Sell
1,401,556
-684,539
-33% -$3.49M ﹤0.01% 1966
2019
Q1 		$10.5M Sell
2,086,095
-3,526,664
-63% -$22.4M ﹤0.01% 1844
2018
Q4 		$53M Buy
5,612,759
+403,086
+8% +$3.81M 0.01% 1113
2018
Q3 		$41.7M Buy
5,209,673
+1,166,524
+29% +$11.7M ﹤0.01% 1358
2018
Q2 		$37.6M Sell
4,043,149
-1,433,946
-26% -$14.2M ﹤0.01% 1419
2018
Q1 		$56.6M Buy
5,477,095
+11,556
+0.2% +$141K 0.01% 1236
2017
Q4 		$70M Buy
5,465,539
+1,207,592
+28% +$14.2M 0.01% 1140
2017
Q3 		$48.1M Buy
4,257,947
+750,727
+21% +$6.42M 0.01% 1318
2017
Q2 		$30.9M Buy
3,507,220
+6,317
+0.2% +$58.5K ﹤0.01% 1504
2017
Q1 		$36.3M Sell
3,500,903
-136,499
-4% -$1.67M ﹤0.01% 1459
2016
Q4 		$46.3M Buy
3,637,402
+428,815
+13% +$5.94M 0.01% 1339
2016
Q3 		$52.8M Buy
+3,208,587
New +$55.4M 0.01% 1267

Other funds holding ACIU

BI
BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
RG
Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return
PIM
Platinum Investment Management Sydney Australia 2000, Australia $397M AUM 63.96% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $303B AUM 30.15% 1-Year Est. Return
Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Handelsbanken Fonder
Handelsbanken Fonder Stockholm, Sweden $35.1B AUM 47.76% 1-Year Est. Return

Fidelity Investments's ACIU Position: Q3 2024 in Review

Fidelity Investments sold out of AC Immune (ACIU) in Q3 2024, closing a stake of 27,202 shares — an estimated $109K sold.

Fidelity Investments first reported a position in ACIU in Q3 2016 and held it in 27 quarters. The position peaked at $70M in Q4 2017. 43 funds tracked by Wall St. Rank hold ACIU as of Q3 2024.

  • Fidelity Investments reported no remaining AC Immune position as of Q3 2024 after selling out during the quarter.
  • Fidelity Investments sold 27,202 AC Immune shares in Q3 2024, an estimated $109K.
  • Fidelity Investments first reported a position in AC Immune in Q3 2016 and held it in 27 quarters.
  • Fidelity Investments's AC Immune position peaked at $70M in Q4 2017.
  • 43 funds tracked by Wall St. Rank held AC Immune as of Q3 2024.

Based on Fidelity Investments's 13F filing for Q3 2024, filed 13 Nov 2024.